RS114846969 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| LDL cholesterol x physical activity interaction (2df test) | A | — | 2E-252 | PubMed |
| LDL x depression interaction (2df test) | A | OR: 0.69 | 5E-181 | PubMed |
| Cholesteryl Esters to Total Lipids in Large VLDL percentage | A | β: 0.08 | 5E-156 | PubMed |
| Free Cholesterol to Total Lipids in Very Large VLDL percentage | A | β: 0.08 | 6E-132 | PubMed |
| LDL x low social support interaction (2df test) | A | OR: 1.31 | 2E-99 | PubMed |
| Low density lipoprotein cholesterol levels | G | OR: 0.17 | 4E-98 | PubMed |
| Average diameter for LDL particles | A | β: 0.06 | 7E-80 | PubMed |
| Total lipids in very large HDL | A | β: 0.04 | 1E-36 | PubMed |
| Coronary artery disease (confirmatory factor analysis Factor 16) | — | — | 1E-26 | PubMed |
| Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | A | β: 0.03 | 2E-23 | PubMed |
| Phospholipids in very large HDL | A | β: 0.03 | 2E-22 | PubMed |
| Omega-3 fatty acid levels | A | — | 1E-20 | PubMed |
| N-palmitoyl-sphingosine (d18:1/16:0) levels | A | OR: 0.14 | 1E-18 | PubMed |
| Stearoyl sphingomyelin (d18:1/18:0) levels | A | OR: 0.13 | 3E-17 | PubMed |
| Ideal cardiovascular health score (clinical and behavioral) | A | β: 0.08 | 3E-17 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | A | β: 0.02 | 2E-16 | PubMed |
| Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | A | OR: 0.12 | 1E-14 | PubMed |
| Angina | — | — | 9E-14 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | A | β: 0.02 | 2E-13 | PubMed |
| Lipoprotein-associated phospholipase A2 activity | A | β: 0.037 | 9E-13 | PubMed |